Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

IDO Inhibitor Study for Relapsed or Refractory Solid Tumors (D-1MT)

This study has been terminated.
(Lack of enrollment.)
Sponsor:
Information provided by (Responsible Party):
NewLink Genetics Corporation
ClinicalTrials.gov Identifier:
NCT00739609
First received: August 20, 2008
Last updated: January 8, 2013
Last verified: January 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: October 2012
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)
No publications provided by NewLink Genetics Corporation

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):